Cellink AB logo

CLNK B - Cellink AB Share Price

SEK191.6 -7.2  -3.6%

Last Trade - 26/10/20

Mid Cap
Market Cap £800.1m
Enterprise Value £735.0m
Revenue £15.5m
Position in Universe 321st / 1791
Unlock CLNK B Revenue
Relative Strength (%)
1m +3.68%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -11.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Aug 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 3.62 13.2 45.3 105.5 176.8 597 861 +164.4%
-54.7 +272.2
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 August 2020, Cellink ABrevenues increased 68% to SEK176.8M. Net loss totaledSEK62.2M vs. income of SEK581K. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Net loss reflects Labor& Related Expenses increase from SEK59.8M to SEK127.2M(expense), External Expenses increase of 87% to SEK85.6M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CLNK B
Graphical History


CLNK B Revenue Unlock CLNK B Revenue

Net Income

CLNK B Net Income Unlock CLNK B Revenue

Normalised EPS

CLNK B Normalised EPS Unlock CLNK B Revenue

PE Ratio Range

CLNK B PE Ratio Range Unlock CLNK B Revenue

Dividend Yield Range

CLNK B Dividend Yield Range Unlock CLNK B Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CLNK B EPS Forecasts Unlock CLNK B Revenue
Profile Summary

Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company operates as a provider of advanced bioprinting solutions for healthcare sector. The Company offers 3D bioprinting of human tissues and organs. The Company's technology facilitates the biofabrication of cell-laden anatomical structures with controlled cell density and homogenous distribution of viable cells. The cell-laden bioink structures are then cultured in vitro, under controlled conditions for a wide range of experiments. In addition, bioprinting with human cells can be combined with computer-aided design (CAD) and computer-aided manufacturing (CAM) using medical images from CT or MRI scans to create a blueprint (3D model) for bioprinting of patient-specific tissues and organs.

Last Annual August 31st, 2020
Last Interim August 31st, 2020
Public Since November 3, 2016
No. of Shareholders: n/a
No. of Employees: 199
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 47,537,253
Free Float (0.0%)
Eligible for
CLNK B Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CLNK B
Upcoming Events for CLNK B
Frequently Asked Questions for Cellink AB
What is the Cellink AB share price?

As of 26/10/20, shares in Cellink AB are trading at SEK191.6, giving the company a market capitalisation of £800.1m. This share price information is delayed by 15 minutes.

How has the Cellink AB share price performed this year?

Shares in Cellink AB are currently trading at SEK191.6 and the price has moved by 0.177k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cellink AB price has moved by 0.209k% over the past year.

What are the analyst and broker recommendations for Cellink AB?

There are no analysts currently covering Cellink AB.

When will Cellink AB next release its financial results?

Cellink AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-08-31
What is the Cellink AB dividend yield?

Cellink AB does not currently pay a dividend.

Does Cellink AB pay a dividend?

Cellink AB does not currently pay a dividend.

When does Cellink AB next pay dividends?

Cellink AB does not currently pay a dividend.

How do I buy Cellink AB shares?

To buy shares in Cellink AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cellink AB?

Shares in Cellink AB are currently trading at SEK191.6, giving the company a market capitalisation of £800.1m.

Where are Cellink AB shares listed? Where are Cellink AB shares listed?

Here are the trading details for Cellink AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: CLNK B
What kind of share is Cellink AB?

Based on an overall assessment of its quality, value and momentum, Cellink AB is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cellink AB share price forecast 2020?

Shares in Cellink AB are currently priced at SEK191.6. At that level they are trading at 20.04% discount to the analyst consensus target price of 0.00.

Analysts covering Cellink AB currently have a consensus Earnings Per Share (EPS) forecast of 0.54 for the next financial year.

How can I tell whether the Cellink AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cellink AB. Over the past six months, the relative strength of its shares against the market has been 32.55%. At the current price of SEK191.6, shares in Cellink AB are trading at 41.78% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cellink AB PE Ratio?

We were not able to find PE ratio data for Cellink AB.

Who are the key directors of Cellink AB?

Cellink AB's management team is headed by:

Erik Gatenholm - CEO
Hector Martinez - CTO
Gusten Danielsson - CFO
Bengt Sjoholm - IND
Ingela Hallberg - IND
Carsten Browall - CHM
Christian Wildmoser - IND
Helena Skantorp - IND
Who are the major shareholders of Cellink AB?

Here are the top five shareholders of Cellink AB based on the size of their shareholding:

Gatenholm (Erik) Individual Investor
Percentage owned: 18.66% (9.35m shares)
Martinez (Hector) Individual Investor
Percentage owned: 13.2% (6.61m shares)
Handelsbanken Asset Management Investment Advisor/Hedge Fund
Percentage owned: 6.98% (3.50m shares)
Handelsbanken Svenska Smabolagsfond Mutual Fund
Percentage owned: 4.24% (2.13m shares)
Fore C Investment Holding AB Corporation
Percentage owned: 4.21% (2.11m shares)
Similar to CLNK B
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.